The Role of Gnrh Analogues in 36-Month Disease-Free Survival in Non-Menopausal Patients with Hormone Receptor-Positive Breast Cancer

The Role of Gnrh Analogues in 36-Month Disease-Free Survival in Non-Menopausal Patients with Hormone Receptor-Positive Breast Cancer

BACKGROUND AND OBJECTIVE: The effectiveness of ovarian function suppression therapies in patients with non-menopausal breast cancer has not yet been established. This study was performed to evaluate the role of gonadotropin-releasing hormone agonist (GnRH agonist) receptor in reducing local recurren...

Full description

Bibliographic Details
Main Authors: S Akbarzadeh Pasha, A Gholizadeh Pasha, M Raanaee, A Moghadamnia, A Vallard, D Moslemi
Format: Article
Language:English
Published: Babol University of Medical Sciences 2020-03-01
Series:Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul
Subjects:
breast neoplasm
triptorelin
gonadotropin-releasing hormone (gnrh)
erbb-2 receptor.
Online Access:http://jbums.org/article-1-9484-en.html

Internet

http://jbums.org/article-1-9484-en.html

Similar Items